Follow
Ioannis Parodis
Ioannis Parodis
Adjunct lecturer, Karolinska Institutet
Verified email at ki.se - Homepage
Title
Cited by
Cited by
Year
2019 update of the joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the …
A Fanouriakis, M Kostopoulou, K Cheema, HJ Anders, M Aringer, ...
Annals of the rheumatic diseases 79 (6), 713-723, 2020
8292020
Lupus nephritis
HJ Anders, R Saxena, M Zhao, I Parodis, JE Salmon, C Mohan
Nature reviews Disease primers 6 (1), 7, 2020
8042020
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
A Fanouriakis, M Kostopoulou, J Andersen, M Aringer, L Arnaud, SC Bae, ...
Annals of the rheumatic diseases 83 (1), 15-29, 2024
4232024
B cell alterations during BAFF inhibition with belimumab in SLE
D Ramsköld, I Parodis, T Lakshmikanth, N Sippl, M Khademi, Y Chen, ...
EBioMedicine 40, 517-527, 2019
1252019
Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus
I Parodis, C Sjöwall, A Jönsen, D Ramsköld, A Zickert, M Frodlund, ...
Autoimmunity reviews 16 (4), 343-351, 2017
1122017
Prediction of prognosis and renal outcome in lupus nephritis
I Parodis, F Tamirou, FA Houssiau
Lupus science & medicine 7 (1), e000389, 2020
1112020
Cardiovascular disease in systemic lupus erythematosus: recent data on epidemiology, risk factors and prevention
M Kostopoulou, D Nikolopoulos, I Parodis, G Bertsias
Current Vascular Pharmacology 18 (6), 549-565, 2020
1082020
The CD6/ALCAM pathway promotes lupus nephritis via T cell–mediated responses
SA Chalmers, RA Ramachandran, SJ Garcia, E Der, L Herlitz, J Ampudia, ...
The Journal of Clinical Investigation 132 (1), 2022
742022
B cell therapy in systemic lupus erythematosus: from rationale to clinical practice
I Parodis, M Stockfelt, C Sjöwall
Frontiers in Medicine 7, 316, 2020
712020
Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis
I Parodis, C Adamichou, S Aydin, A Gomez, N Demoulin, ...
Rheumatology 59 (11), 3424-3434, 2020
652020
Interferon (IFN)-λ is a potential mediator in lupus nephritis
A Zickert, V Oke, I Parodis, E Svenungsson, Y Sundström, I Gunnarsson
Lupus science & medicine 3 (1), e000170, 2016
602016
EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis
I Parodis, C Girard-Guyonvarc’h, L Arnaud, O Distler, A Domján, ...
Annals of the Rheumatic Diseases 83 (6), 720-729, 2024
562024
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol
P Sen, L Gupta, JB Lilleker, V Aggarwal, S Kardes, M Milchert, T Gheita, ...
Rheumatology international 42 (1), 23-29, 2022
562022
ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus
I Parodis, S Gokaraju, A Zickert, K Vanarsa, T Zhang, D Habazi, J Botto, ...
Rheumatology 59 (9), 2237-2249, 2020
532020
Fatigue in systemic lupus erythematosus: an update on its impact, determinants and therapeutic management
L Kawka, A Schlencker, P Mertz, T Martin, L Arnaud
Journal of Clinical Medicine 10 (17), 3996, 2021
492021
Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following …
I Parodis, A Zickert, B Sundelin, M Axelsson, J Gerhardsson, ...
Lupus science & medicine 2 (1), e000061, 2015
482015
COVAD survey 2 long-term outcomes: unmet need and protocol
ZZ Fazal, P Sen, M Joshi, N Ravichandran, JB Lilleker, V Agarwal, ...
Rheumatology international 42 (12), 2151-2158, 2022
462022
Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus
I Parodis, P Johansson, A Gomez, S Soukka, S Emamikia, ...
Rheumatology 58 (12), 2170-2176, 2019
462019
Adverse health-related quality of life outcome despite adequate clinical response to treatment in systemic lupus erythematosus
A Gomez, V Qiu, A Cederlund, A Borg, J Lindblom, S Emamikia, Y Enman, ...
Frontiers in Medicine 8, 651249, 2021
452021
Biologics in SLE: towards new approaches
RF van Vollenhoven, I Parodis, A Levitsky
Best Practice & Research Clinical Rheumatology 27 (3), 341-349, 2013
452013
The system can't perform the operation now. Try again later.
Articles 1–20